Flavor Of The Month: Bass Metals And More

In This Article:

Bass Metals and Westgold Resources are a few noticeable companies with a strong future outlook. The market’s optimistic sentiment towards these stocks indicates a level of confidence in the future outlook of their businesses. Investment in growth companies can benefit your current holdings, whether it be in established tech giants or undiscovered micro-caps. Here, I’ve put together a few companies the market is particularly optimistic towards.

Bass Metals Limited (ASX:BSM)

Bass Metals Limited engages in graphite mining. The company currently employs 130 people and with the company’s market cap sitting at AUD A$46.61M, it falls under the small-cap stocks category.

An outstanding 77.77% earnings growth is forecasted for BSM, driven by strong underlying sales growth over the next few years. It appears that BSM’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. BSM’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Interested to learn more about BSM? Take a look at its other fundamentals here.

ASX:BSM Future Profit Mar 12th 18
ASX:BSM Future Profit Mar 12th 18

Westgold Resources Limited (ASX:WGX)

Westgold Resources Limited engages in the exploration, development, mining, and treatment of gold assets in Western Australia. Established in 1987, and headed by CEO Peter Cook, the company employs 371 people and with the stock’s market cap sitting at AUD A$553.70M, it comes under the small-cap stocks category.

Extreme optimism for WGX, as market analysts projected an outstanding earnings growth rate of 89.84% for the stock, supported by an equally strong sales growth of 62.56%. It appears that WGX’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 22.52%. WGX’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about WGX? Check out its fundamental factors here.

ASX:WGX Future Profit Mar 12th 18
ASX:WGX Future Profit Mar 12th 18

Medibio Limited (ASX:MEB)

Medibio Limited, a medical technology company, engages in the research, development, and commercialization of medical diagnostic technology for mental health based on circadian heart rate data in Australia. Medibio was started in 1998 and with the market cap of AUD A$47.10M, it falls under the small-cap stocks category.